Baseball in 2015: Record High Revenues

Baseball in 2015: Record High Revenues

A man speaks with a job recruiter at the Nassau County Mega Job Fair at Nassau Veterans Memorial Coliseum in Uniondale, New York October 7, 2014.  REUTERS/Shannon Stapleton
By Andrew Lumby

e 2015 Major League Baseball season gets underway on Monday with the sport dealing with an aging, shrinking television audience—yet league revenues, franchise valuations and player salaries are all rising faster than the stock market.

With the average MLB team now worth more than $1.2 billion and the average salary breaking $4 million, let's take a look at how the business of baseball has changed in the last few years.

A shrinking, aging television audience

"The five most-watched World Series aired in the five-year period between 1978 and 1982," said Brad Adgate of Horizon Media. All five averaged more than 38 million viewers. Contrast that with the 2014 World Series audience—a skinny 13.8 million—down 64 percent despite an increased U.S. population. Media buyer Adgate said that's "unlike the Super Bowl, which has set an audience record in five of the last six years."

Related: Madison Bumgarner: Exhibit A in Baseball’s Screwball Salary System

Not only is the audience declining, but it's aging too: Last year's World Series had a viewer with a median age of 55.6—a new high. Just five years prior, it had been sub-50 at 49.9, and was in the 44-46 range during the early 1990s.

Chart of the Day: Boosting Corporate Tax Revenues

GraphicStock
By The Fiscal Times Staff

The leading candidates for the Democratic presidential nomination have all proposed increasing taxes on corporations, including raising income tax rates to levels ranging from 25% to 35%, up from the current 21% imposed by the Republican tax cuts in 2017. With Bernie Sanders leading the way at $3.9 trillion, here’s how much revenue the higher proposed corporate taxes, along with additional proposed surtaxes and reduced tax breaks, would generate over a decade, according to calculations by the right-leaning Tax Foundation, highlighted Wednesday by Bloomberg News.

Chart of the Day: Discretionary Spending Droops

By The Fiscal Times Staff

The federal government’s total non-defense discretionary spending – which covers everything from education and national parks to veterans’ medical care and low-income housing assistance – equals 3.2% of GDP in 2020, near historic lows going back to 1962, according to an analysis this week from the Center on Budget and Policy Priorities.

Chart of the Week: Trump Adds $4.7 Trillion in Debt

By The Fiscal Times Staff

The Committee for a Responsible Federal Budget estimated this week that President Trump has now signed legislation that will add a total of $4.7 trillion to the national debt between 2017 and 2029. Tax cuts and spending increases account for similar portions of the projected increase, though if the individual tax cuts in the 2017 Republican overhaul are extended beyond their current expiration date at the end of 2025, they would add another $1 trillion in debt through 2029.

Chart of the Day: The Long Decline in Interest Rates

Wall Street slips, Dow posts biggest weekly loss of 2013
Reuters
By The Fiscal Times Staff

Are interest rates destined to move higher, increasing the cost of private and public debt? While many experts believe that higher rates are all but inevitable, historian Paul Schmelzing argues that today’s low-interest environment is consistent with a long-term trend stretching back 600 years.

The chart “shows a clear historical downtrend, with rates falling about 1% every 60 years to near zero today,” says Bloomberg’s Aaron Brown. “Rates do tend to revert to a mean, but that mean seems to be declining.”

Chart of the Day: Drug Price Plans Compared

By The Fiscal Times Staff

Lawmakers are considering three separate bills that are intended to reduce the cost of prescription drugs. Here’s an overview of the proposals, from a series of charts produced by the Kaiser Family Foundation this week. An interesting detail highlighted in another chart: 88% of voters – including 92% of Democrats and 85% of Republicans – want to give the government the power to negotiate prices with drug companies.